Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke.

OBJECTIVE: We examined the influence of clinical, radiologic, and echocardiographic characteristics on antithrombotic choice in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO), hypothesizing that features suggestive of paradoxical embolism might lead to greater use of anticoagulation. METHODS: The Risk of Paradoxical Embolism Study combined 12 databases to create the largest dataset of patients with CS and known PFO status. We used generalized linear mixed models with a random effect of component study to explore whether anticoagulation was preferentially selected based on the following: (1) younger age and absence of vascular risk factors, (2) "high-risk" echocardiographic features, and (3) neuroradiologic findings. RESULTS: A total of 1,132 patients with CS and PFO treated with anticoagulation or antiplatelets were included. Overall, 438 participants (39%) were treated with anticoagulation with a range (by database) of 22% to 54%. Treatment choice was not influenced by age or vascular risk factors. However, neuroradiologic findings (superficial or multiple infarcts) and high-risk echocardiographic features (large shunts, shunt at rest, and septal hypermobility) were predictors of anticoagulation use. CONCLUSION: Both antithrombotic regimens are widely used for secondary stroke prevention in patients with CS and PFO. Radiologic and echocardiographic features were strongly associated with treatment choice, whereas conventional vascular risk factors were not. Prior observational studies are likely to be biased by confounding by indication.

A lower bound in Nehari's theorem on the polydisc

By theorems of Ferguson and Lacey ($d=2$) and Lacey and Terwilleger ($d>2$), Nehari's theorem is known to hold on the polydisc $\D^d$ for $d>1$, i.e., if $H_\psi$ is a bounded Hankel form on $H^2(\D^d)$ with analytic symbol $\psi$, then there is a function $\varphi$ in $L^\infty(\T^d)$ such that $\psi$ is the Riesz projection of $\varphi$. A method proposed in Helson's last paper is used to show that the constant $C_d$ in the estimate $\|\varphi\|_\infty\le C_d \|H_\psi\|$ grows at least exponentially with $d$; it follows that there is no analogue of Nehari's theorem on the infinite-dimensional polydisc.

Traducció del testament de Charles Robert Darwin

L’objectiu principal d’aquest treball és assumir el que podria ser un encàrrec real d’un text jurídic. Així que, en aquest treball es tradueix un testament. Els testaments són documents a través dels quals una persona disposa els seus béns per tal que després de la seva mort una altra se’n faci càrrec. El testament escollit ha estat el de Charles Robert Darwin, que va morir el 19 d’abril de 1882 a Down, en el comptat de Kent, Anglaterra, on hi visqué 40 anys, des del 1842 fins la seva mort. Aquest testament té unes particularitats concretes, ja que fa uns 190 anys que es va firmar. El dret successori anglès, regit per la Llei de successions de protecció de la família i tuïció de 1975 és molt diferent del dret successori català. Així doncs, coneixerem les diferències entre el dret successori català i l’anglès. També, veurem tots passos que han estat necessaris per portar a terme aquest treball.

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-standardised adult prevalence of diabetes at its 2010 levels. We aimed to estimate worldwide trends in diabetes, how likely it is for countries to achieve the global target, and how changes in prevalence, together with population growth and ageing, are affecting the number of adults with diabetes. We pooled data from population-based studies that had collected data on diabetes through measurement of its biomarkers. We used a Bayesian hierarchical model to estimate trends in diabetes prevalence-defined as fasting plasma glucose of 7.0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs-in 200 countries and territories in 21 regions, by sex and from 1980 to 2014. We also calculated the posterior probability of meeting the global diabetes target if post-2000 trends continue. We used data from 751 studies including 4,372,000 adults from 146 of the 200 countries we make estimates for. Global age-standardised diabetes prevalence increased from 4.3% (95% credible interval 2.4-7.0) in 1980 to 9.0% (7.2-11.1) in 2014 in men, and from 5.0% (2.9-7.9) to 7.9% (6.4-9.7) in women. The number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014 (28.5% due to the rise in prevalence, 39.7% due to population growth and ageing, and 31.8% due to interaction of these two factors). Age-standardised adult diabetes prevalence in 2014 was lowest in northwestern Europe, and highest in Polynesia and Micronesia, at nearly 25%, followed by Melanesia and the Middle East and north Africa. Between 1980 and 2014 there was little change in age-standardised diabetes prevalence in adult women in continental western Europe, although crude prevalence rose because of ageing of the population. By contrast, age-standardised adult prevalence rose by 15 percentage points in men and women in Polynesia and Micronesia. In 2014, American Samoa had the highest national prevalence of diabetes (>30% in both sexes), with age-standardised adult prevalence also higher than 25% in some other islands in Polynesia and Micronesia. If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is lower than 1% for men and is 1% for women. Only nine countries for men and 29 countries for women, mostly in western Europe, have a 50% or higher probability of meeting the global target. Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchanged, in every country. Together with population growth and ageing, this rise has led to a near quadrupling of the number of adults with diabetes worldwide. The burden of diabetes, both in terms of prevalence and number of adults affected, has increased faster in low-income and middle-income countries than in high-income countries. Wellcome Trust.

Luoton historia Venetsiasta myrkyllisiin mutaatioihin

Kirjallisuusarvostelu

Avaliação do nível de ruído em colhedoras combinadas

O presente trabalho teve o objetivo de determinar os níveis de pressão sonora nas cabines de colhedoras combinadas, por meio do uso de um medidor de nível de pressão sonora. Foram avaliadas as colhedoras New Holland TC-57, SLC 6200 e Massey Ferguson 3640, sendo determinado o nível de ruído na cabine do operador. O delineamento adotado foi o inteiramente casualizado, com 12 tratamentos e três repetições. Os resultados obtidos evidenciam que todas as colhedoras estudadas apresentaram ruído acima do nível máximo estabelecido pelas normas técnicas.

Kirja-arvostelu : Handbook of veterinary neurology

Kirjallisuusarvostelu

Miten masteroida Reasonilla? : musiikkiohjelmistojen käyttäjät ja populaarimusiikin tuottamisen tekniikat

Johdanto ; Tutkimusnäkökulmia musiikkiteknologiaan ; Musiikkiteknologiat sosiaalisina teknologioina ; Musiikillisia teknokulttuureja? ; Tekniikat - musiikin tuottamisen ja kuuntelemisen käytännöt ; Musiikin tuottamisen tekniikat tietokoneohjelmilla ; Musiikin tekeminen Reason-ohjelmistolla ; Kaksi Reasonin käyttäjää ja musiikin tuottamisen tekniikat ; Masterointia Reasonilla ; Yhteisöllisyys.

Stephen Hawkingin maailma

Kirjallisuusarvostelu

Using green fluorescent protein to understand the mechanisms of G-protein-coupled receptor regulation

G protein-coupled receptor (GPCR) activation is followed rapidly by adaptive changes that serve to diminish the responsiveness of a cell to further stimulation. This process, termed desensitization, is the consequence of receptor phosphorylation, arrestin binding, sequestration and down-regulation. GPCR phosphorylation is initiated within seconds to minutes of receptor activation and is mediated by both second messenger-dependent protein kinases and receptor-specific G protein-coupled receptor kinases (GRKs). Desensitization in response to GRK-mediated phosphorylation involves the binding of arrestin proteins that serve to sterically uncouple the receptor from its G protein. GPCR sequestration, the endocytosis of receptors to endosomes, not only contributes to the temporal desensitization of GPCRs, but plays a critical role in GPCR resensitization. GPCR down-regulation, a loss of the total cellular complement of receptors, is the consequence of both increased lysosomal degradation and decreased mRNA synthesis of GPCRs. While each of these agonist-mediated desensitization processes are initiated within a temporally dissociable time frame, recent data suggest that they are intimately related to one another. The use of green fluorescent protein from the jellyfish Aqueora victoria as an epitope tag with intrinsic fluorescence has facilitated our understanding of the relative relationship between GRK phosphorylation, arrestin binding, receptor sequestration and down-regulation.